Skip to main content
Sustained Control Reported for Anti–IL-17, Anti–IL-23 Psoriasis Treatments
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Sustained Control Reported for Anti–IL-17, Anti–IL-23 Psoriasis Treatments
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriasis
1
1
Interleukin
0
0.52
Plaque Psoriasis
0
0.52
Biologic Therapy
0
0.49
Nasopharyngitis
0
0.35
Scalp
0
0.35
Otolaryngology
0
0.2
Clinical Research
0
0.17
Monoclonal Antibody
0
0.17
New York
0
0.17
Oral Candidiasis
0
0.17
Pennsylvania
0
0.17
Receptors
0
0.17
Severity Index
0
0.17
Dentistry and Oral Health
0
0.14
Fungal Infection
0
0.14
Candidiasis
0
0.1
Healthcare and Medical Technology
0
0.1
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Rheumatology
0
0.8
Pharmacist
0
0.7
Edit Tags